News | Cath Lab

March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help improve ...

Home March 21, 2018
Home
Videos | ACC

DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018 ...

Home March 21, 2018
Home
Videos | Womens Cardiovascular Health

A discussion with Doreen DeFaria Yeh, M.D., associate director, Massachusetts General Hospital Adult Congenital Heart ...

Home March 21, 2018
Home
News | ACC

Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presented ...

Home March 21, 2018
Home
News | ACC

March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — Febuxostat, a gout drug that has been in use for nearly a decade, was found to significantly increase ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — The anti-inflammatory drug canakinumab had no effect on rates of newly diagnosed diabetes in people who ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart attack ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — Among people younger than 75 years who were given clot busters to treat a heart attack, taking the more ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — When patients who had a heart attack were given vouchers to cover their co-payments for medication to ...

Home March 20, 2018
Home
Edwards Lifesciences received European CE mark clearance for its self-expanding Centera transcatheter aortic valve replacement (TAVR) device for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery.
Feature | Dave Fornell

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — Patients with acute coronary syndrome experienced a substantially lower rate of heart attack, stroke ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — A pill combining low doses of three blood pressure-lowering medications significantly increased the ...

Home March 20, 2018
Home
Subscribe Now